(Q33337730)

English

Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: a phase II trial of the Minnie Pearl Cancer Research Network

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: a phase II trial of the Minnie Pearl Cancer Research Network (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

phase II clinical trial

0 references

carcinoma of unknown primary

1 reference

based on heuristic

inferred from title

author name string

J D Hainsworth

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

H A Burris

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

S W Calvert

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

N T Willcutt

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

D C Scullin

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

J Bramham

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

F A Greco

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Cancer Investigation

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

335-339

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

5-fluorouracil, adriamycin, and mitomycin in the treatment of adenocarcinoma of unknown primary

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103127

21 January 2018

Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103127

21 January 2018

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103127

21 January 2018

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103127

21 January 2018

Advanced breast cancer: a phase II trial with gemcitabine

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103127

21 January 2018

Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) in previously treated ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103127

21 January 2018

Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103127

21 January 2018

Treatment of the patient with adenocarcinoma of unknown origin

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103127

21 January 2018

Continuous infusion 5-fluorouracil, etoposide and cis-diamminedichloroplatinum in patients with metastatic carcinoma of unknown primary origin

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103127

21 January 2018

Metastatic adenocarcinomas of unknown primary site: a randomized study of two combination-chemotherapy regimens

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103127

21 January 2018

Fluorouracil, doxorubicin, cisplatin and altretamine in the treatment of metastatic carcinoma of unknown primary

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103127

21 January 2018

Lack of value for cisplatin added to mitomycin-doxorubicin combination chemotherapy for carcinoma of unknown primary site. A randomized trial

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103127

21 January 2018

Efficacy of gemcitabine in the treatment of patients with gallbladder carcinoma: a case report

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103127

21 January 2018

Identifiers

10.1081/CNV-100103127

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33337730&oldid=1628499815"